Related Experiment Video
Updated: Jan 30, 2026

Cell-based Assay Protocol for the Prognostic Prediction of Idiopathic Scoliosis Using Cellular Dielectric Spectroscopy
Published on: October 16, 2013
Predicting Which Children with Juvenile Idiopathic Arthritis Will Not Attain Early Remission with Conventional
Jaime Guzman1,2,3, Andrew Henrey4,5,6, Thomas Loughin4,5,6
1From the British Columbia Children's Hospital and the University of British Columbia, Vancouver; Simon Fraser University, Burnaby, British Columbia; London Health Sciences Centre and Western University, London; Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, Ontario; IWK Health Centre and Dalhousie University, Halifax, Nova Scotia; Winnipeg Children's Hospital and University of Manitoba, Winnipeg, Manitoba; Hospital for Sick Children and University of Toronto, Toronto, Ontario; McGill University Health Centre and McGill University, Montreal, Quebec; Janeway Children's Health and Rehabilitation Centre and Memorial University, Saint John's, Newfoundland and Labrador; Royal University Hospital and University of Saskatchewan, Saskatoon, Saskatchewan; Centre Hospitalier Universitaire Sainte-Justine and Université de Montréal, Montreal; Centre Hospitalier Universitaire de Sherbrooke and Université de Sherbrooke, Sherbrooke, Quebec; Alberta Children's Hospital and University of Calgary, Alberta, Canada; Shands Children's Hospital and University of Florida, Gainesville, Florida, USA. jguzman@cw.bc.ca.
Insights
Predicting early remission in juvenile idiopathic arthritis (JIA) is crucial. A new model identifies more children with low remission chances, potentially guiding early biologic or triple disease-modifying antirheumatic drug (DMARD) treatment.
Area of Science:
- Pediatric Rheumatology
- Clinical Prediction Modeling
Background:
- Juvenile idiopathic arthritis (JIA) management requires predicting treatment response.
- Identifying children unlikely to achieve remission with conventional therapy is key for optimizing treatment strategies.
Purpose of the Study:
- To estimate the probability of early remission in children with JIA using conventional treatment.
- To identify candidates for upfront biologic or triple disease-modifying antirheumatic drug (DMARD) therapy based on low remission probability.
Main Methods:
- Utilized data from 1074 children in the Research in Arthritis in Canadian Children emphasizing Outcomes (ReACCh-Out) cohort.
- Developed and tested Cox logistic regression models on random splits of the cohort to predict clinically inactive disease within one year.
- Evaluated model performance using c-index and compared predictions with observed remission rates.
Main Results:
- The best model, incorporating 18 clinical variables, achieved a c-index of 0.69, outperforming JIA category alone (0.59).
- The model identified 14% of subjects with a low chance of remission (<0.25 probability), of whom 77% did not achieve remission.
- Children in the lowest probability decile had a 20% chance of remission, while those in the highest had a 69% chance.
Conclusions:
- The developed model, while not meeting the c-index > 0.70 threshold, significantly improved identification of JIA patients with a low probability of early remission compared to JIA category alone.
- This model can serve as a benchmark for future research incorporating laboratory or imaging biomarkers to enhance JIA treatment decisions.
Objective:
To estimate the probability of early remission with conventional treatment for each child with juvenile idiopathic arthritis (JIA). Children with a low chance of remission may be candidates for initial treatment with biologics or triple disease-modifying antirheumatic drugs (DMARD).
Methods:
We used data from 1074 subjects in the Research in Arthritis in Canadian Children emphasizing Outcomes (ReACCh-Out) cohort. The predicted outcome was clinically inactive disease for ≥ 6 months starting within 1 year of JIA diagnosis in patients who did not receive early biologic agents or triple DMARD. Models were developed in 200 random splits of 75% of the cohort and tested on the remaining 25% of subjects, calculating expected and observed frequencies of remission and c-index values.
Results:
Our best Cox logistic model combining 18 clinical variables a median of 2 days after diagnosis had a c-index of 0.69 (95% CI 0.67-0.71), better than using JIA category alone (0.59, 95% CI 0.56-0.63). Children in the lowest probability decile had a 20% chance of remission and 21% attained remission; children in the highest decile had a 69% chance of remission and 73% attained remission. Compared to 5% of subjects identified by JIA category alone, the model identified 14% of subjects as low chance of remission (probability < 0.25), of whom 77% failed to attain remission.
Conclusion:
Although the model did not meet our a priori performance threshold (c-index > 0.70), it identified 3 times more subjects with low chance of remission than did JIA category alone, and it may serve as a benchmark for assessing value added by future laboratory/imaging biomarkers.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
07:20Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
Related Concept Videos
Sign Convention
The normal force acts perpendicular to the beam's cross-section and can...
Predicting Molecular Geometry
Enolate Mechanism Conventions
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
End Point Prediction: Gran Plot
For potentiometric titration, the Gran plot is created by plotting...
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...